Valuation: GuiZhou SanLi Pharmaceutical Co.,Ltd

Market Cap 4.36B 653M 590M 545M 493M 930M 61.34B 958M 6.54B 2.6B 32.8B 2.45B 2.4B 104B P/E 2024
19.4x
P/E 2025 106x
Enterprise Value 4.7B 705M 637M 588M 532M 1B 66.26B 1.03B 7.06B 2.81B 35.42B 2.65B 2.59B 113B EV / Sales 2024
2.48x
EV / Sales 2025 2.99x
Free-Float
40.59%
Yield 2024
2.62%
Yield 2025 0.51%
1 week-3.63%
Current month+2.73%
1 month-5.46%
3 months-13.49%
6 months-11.45%
Current year-6.84%
1 week 10.81
Extreme 10.81000000
11.21
1 month 10.4
Extreme 10.4
11.95
Current year 9.51
Extreme 9.51
17.46
1 year 9.51
Extreme 9.51
17.46
3 years 9.51
Extreme 9.51
20.34
5 years 9.51
Extreme 9.51
21.28
10 years 8.82
Extreme 8.82
44.1
Manager TitleAgeSince
Chief Executive Officer 41 27/05/2024
Chief Executive Officer 41 01/09/2011
Director of Finance/CFO 39 01/11/2024
Director TitleAgeSince
Chairman 41 01/03/2018
Director/Board Member 41 01/03/2018
Director/Board Member 52 28/01/2015
Date Insider Type Main position Quantity % Market Cap. Importance
11/9/24 Sell

Chief Executive Officer

21,000,000 5.1428%
2/8/24 Buy

Director

13,000 0.0032%
5/8/23 Sell 25,000 0.0061%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-3.63%-13.29%-43.67% 653M
-0.70%+4.58%+40.23%+138.79% 1,271B
+1.11%+4.11%+45.85%+92.54% 683B
-0.18%+2.15%+26.25%+112.46% 520B
-0.75%+3.46%+39.29%+69.13% 389B
-0.16%+0.01%+60.69%+44.94% 362B
-0.15%+0.87%+26.95%+58.64% 304B
+0.08%+0.17%+3.41%+36.16% 286B
-0.22%+1.47%+38.89%+74.73% 253B
-1.05%+0.23%+36.10%+121.22% 208B
Average -0.01%+1.61%+30.44%+70.49% 428B
Weighted average by Cap. +0.12%+2.67%+37.38%+96.70%

Financials

2024 2025
Net sales 2.14B 321M 290M 268M 243M 458M 30.2B 472M 3.22B 1.28B 16.14B 1.21B 1.18B 51.39B 1.7B 255M 231M 213M 193M 364M 23.98B 375M 2.56B 1.02B 12.82B 957M 937M 40.81B
Net income 274M 41.05M 37.12M 34.26M 31.01M 58.52M 3.86B 60.28M 411M 163M 2.06B 154M 151M 6.57B 46.25M 6.93M 6.27M 5.78M 5.24M 9.88M 651M 10.17M 69.42M 27.59M 348M 26M 25.45M 1.11B
Net Debt 108M 16.13M 14.58M 13.46M 12.19M 22.99M 1.52B 23.68M 162M 64.22M 811M 60.53M 59.24M 2.58B 349M 52.24M 47.24M 43.6M 39.47M 74.48M 4.91B 76.71M 523M 208M 2.63B 196M 192M 8.36B
Projected Income Statement - Annual - GuiZhou SanLi Pharmaceutical Co.,Ltd
Logo GuiZhou SanLi Pharmaceutical Co.,Ltd
Guizhou Sanli Pharmaceutical Co Ltd is a China-based company primarily engaged in the research, development, production, and sales of pharmaceuticals. The products primarily include respiratory medications, tonics, gynecological medications, orthopedic medications, and cardiovascular medications. The specific pharmaceutical products include Kaihoujian Spray (children's version), Kaihoujian Spray, Qijiao Shengbai Capsules, Fuke Zaizao Pills, Zhike Huatan Pills, Huangqi Granules, and Qiangli Tianma Duzhong Capsules. The Company distributes its products within the domestic market.
Employees
1,887
Date Price Change Volume
12/11/26 CN¥10.90 0.00% 12,529,499
11/11/26 CN¥10.90 -0.82% 8,156,871
10/11/26 CN¥10.99 +0.18% 8,870,900
09/11/26 CN¥10.97 +1.20% 9,743,323
06/11/26 CN¥10.84 -4.16% 10,412,200

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - GuiZhou SanLi Pharmaceutical Co.,Ltd
  1. Stock Market
  2. Stocks
  3. 603439 Stock